ResMed Debt to Equity Ratio 2012-2025 | RMD
Current and historical debt to equity ratio values for ResMed (RMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ResMed debt/equity for the three months ending September 30, 2025 was 0.07.
| ResMed Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $2.19B | $6.12B | 0.36 |
| 2025-06-30 | $2.21B | $5.97B | 0.37 |
| 2025-03-31 | $2.02B | $5.55B | 0.36 |
| 2024-12-31 | $1.89B | $5.25B | 0.36 |
| 2024-09-30 | $2.03B | $5.20B | 0.39 |
| 2024-06-30 | $2.01B | $4.86B | 0.41 |
| 2024-03-31 | $2.19B | $4.63B | 0.47 |
| 2023-12-31 | $2.42B | $4.48B | 0.54 |
| 2023-09-30 | $2.49B | $4.25B | 0.59 |
| 2023-06-30 | $2.62B | $4.13B | 0.64 |
| 2023-03-31 | $2.78B | $3.93B | 0.71 |
| 2022-12-31 | $2.94B | $3.74B | 0.79 |
| 2022-09-30 | $1.75B | $3.43B | 0.51 |
| 2022-06-30 | $1.74B | $3.36B | 0.52 |
| 2022-03-31 | $1.63B | $3.28B | 0.50 |
| 2021-12-31 | $1.59B | $3.15B | 0.51 |
| 2021-09-30 | $1.70B | $3.03B | 0.56 |
| 2021-06-30 | $1.84B | $2.89B | 0.64 |
| 2021-03-31 | $1.88B | $2.71B | 0.69 |
| 2020-12-31 | $1.71B | $2.87B | 0.60 |
| 2020-09-30 | $1.94B | $2.68B | 0.73 |
| 2020-06-30 | $2.09B | $2.50B | 0.84 |
| 2020-03-31 | $2.25B | $2.26B | 1.00 |
| 2019-12-31 | $2.10B | $2.26B | 0.93 |
| 2019-09-30 | $2.04B | $2.12B | 0.96 |
| 2019-06-30 | $2.04B | $2.07B | 0.98 |
| 2019-03-31 | $2.08B | $2.02B | 1.03 |
| 2018-12-31 | $1.90B | $1.96B | 0.97 |
| 2018-09-30 | $1.17B | $1.90B | 0.61 |
| 2018-06-30 | $1.01B | $2.06B | 0.49 |
| 2018-03-31 | $1.47B | $2.07B | 0.71 |
| 2017-12-31 | $1.54B | $2.02B | 0.77 |
| 2017-09-30 | $1.44B | $2.05B | 0.70 |
| 2017-06-30 | $1.51B | $1.96B | 0.77 |
| 2017-03-31 | $1.57B | $1.86B | 0.85 |
| 2016-12-31 | $1.61B | $1.71B | 0.94 |
| 2016-09-30 | $1.55B | $1.77B | 0.87 |
| 2016-06-30 | $1.56B | $1.70B | 0.92 |
| 2016-03-31 | $0.77B | $1.67B | 0.46 |
| 2015-12-31 | $0.72B | $1.52B | 0.47 |
| 2015-09-30 | $0.79B | $1.46B | 0.54 |
| 2015-06-30 | $0.59B | $1.59B | 0.38 |
| 2015-03-31 | $0.74B | $1.54B | 0.48 |
| 2014-12-31 | $0.74B | $1.59B | 0.47 |
| 2014-09-30 | $0.66B | $1.65B | 0.40 |
| 2014-06-30 | $0.60B | $1.76B | 0.34 |
| 2014-03-31 | $0.67B | $1.69B | 0.40 |
| 2013-12-31 | $0.71B | $1.64B | 0.43 |
| 2013-09-30 | $0.64B | $1.69B | 0.38 |
| 2013-06-30 | $0.60B | $1.61B | 0.37 |
| 2013-03-31 | $0.61B | $1.77B | 0.34 |
| 2012-12-31 | $0.58B | $1.75B | 0.33 |
| 2012-09-30 | $0.55B | $1.70B | 0.32 |
| 2012-06-30 | $0.53B | $1.61B | 0.33 |
| 2012-03-31 | $0.52B | $1.61B | 0.32 |
| 2011-12-31 | $0.48B | $1.56B | 0.31 |
| 2011-09-30 | $0.39B | $1.55B | 0.25 |
| 2011-06-30 | $0.34B | $1.73B | 0.20 |
| 2011-03-31 | $0.30B | $1.66B | 0.18 |
| 2010-12-31 | $0.27B | $1.61B | 0.17 |
| 2010-09-30 | $0.32B | $1.48B | 0.21 |
| 2010-06-30 | $0.34B | $1.29B | 0.26 |
| 2010-03-31 | $0.38B | $1.33B | 0.29 |
| 2009-12-31 | $0.36B | $1.26B | 0.29 |
| 2009-09-30 | $0.42B | $1.20B | 0.35 |
| 2009-06-30 | $0.39B | $1.12B | 0.35 |
| 2009-03-31 | $0.35B | $0.97B | 0.36 |
| 2008-12-31 | $0.34B | $0.96B | 0.36 |
| 2008-09-30 | $0.32B | $0.97B | 0.33 |
| 2008-06-30 | $0.32B | $1.08B | 0.30 |
| 2008-03-31 | $0.30B | $1.07B | 0.28 |
| 2007-12-31 | $0.31B | $1.02B | 0.30 |
| 2007-09-30 | $0.31B | $0.98B | 0.31 |
| 2007-06-30 | $0.32B | $0.93B | 0.35 |
| 2007-03-31 | $0.32B | $0.87B | 0.37 |
| 2006-12-31 | $0.28B | $0.85B | 0.33 |
| 2006-09-30 | $0.26B | $0.77B | 0.34 |
| 2006-06-30 | $0.28B | $0.74B | 0.37 |
| 2006-03-31 | $0.23B | $0.67B | 0.33 |
| 2005-12-31 | $0.34B | $0.53B | 0.64 |
| 2005-09-30 | $0.31B | $0.51B | 0.62 |
| 2005-06-30 | $0.30B | $0.47B | 0.63 |
| 2005-03-31 | $0.21B | $0.46B | 0.45 |
| 2004-12-31 | $0.20B | $0.43B | 0.46 |
| 2004-09-30 | $0.19B | $0.38B | 0.49 |
| 2004-06-30 | $0.19B | $0.36B | 0.52 |
| 2004-03-31 | $0.19B | $0.35B | 0.54 |
| 2003-12-31 | $0.17B | $0.33B | 0.52 |
| 2003-09-30 | $0.18B | $0.31B | 0.56 |
| 2003-06-30 | $0.17B | $0.29B | 0.61 |
| 2003-03-31 | $0.18B | $0.25B | 0.72 |
| 2002-12-31 | $0.17B | $0.22B | 0.77 |
| 2002-09-30 | $0.18B | $0.20B | 0.89 |
| 2002-06-30 | $0.18B | $0.19B | 0.95 |
| 2002-03-31 | $0.20B | $0.14B | 1.41 |
| 2001-12-31 | $0.22B | $0.13B | 1.74 |
| 2001-09-30 | $0.23B | $0.12B | 1.93 |
| 2001-06-30 | $0.19B | $0.10B | 1.87 |
| 2001-03-31 | $0.11B | $0.09B | 1.30 |
| 2000-12-31 | $0.03B | $0.11B | 0.30 |
| 2000-09-30 | $0.03B | $0.10B | 0.32 |
| 2000-06-30 | $0.02B | $0.09B | 0.23 |
| 2000-03-31 | $0.02B | $0.09B | 0.28 |
| 1999-12-31 | $0.02B | $0.08B | 0.24 |
| 1999-09-30 | $0.02B | $0.08B | 0.27 |
| 1999-06-30 | $0.02B | $0.07B | 0.26 |
| 1999-03-31 | $0.02B | $0.07B | 0.29 |
| 1998-12-31 | $0.00B | 0.00 | |
| 1998-09-30 | $0.00B | 0.00 | |
| 1998-06-30 | $0.00B | 0.00 | |
| 1998-03-31 | $0.00B | 0.00 | |
| 1997-12-31 | $0.00B | 0.00 | |
| 1997-09-30 | $0.00B | 0.00 | |
| 1997-06-30 | $0.00B | 0.00 | |
| 1997-03-31 | $0.01B | $0.03B | 0.33 |
| 1996-12-31 | $0.01B | $0.03B | 0.31 |
| 1996-09-30 | $0.01B | $0.04B | 0.22 |
| 1996-06-30 | $0.01B | $0.04B | 0.20 |
| 1996-03-31 | $0.01B | $0.03B | 0.20 |
| 1995-12-31 | $0.00B | 0.00 | |
| 1995-09-30 | $0.00B | 0.00 | |
| 1995-06-30 | $0.01B | $0.03B | 0.22 |
| 1995-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.840B | $5.146B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.934B | 24.19 |
| EssilorLuxottica (ESLOY) | France | $146.214B | 0.00 |
| Stryker (SYK) | United States | $138.797B | 27.56 |
| Boston Scientific (BSX) | United States | $135.955B | 31.09 |
| Medtronic (MDT) | Ireland | $128.573B | 17.81 |
| Medline (MDLN) | United States | $56.884B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.666B | 0.00 |
| Agilent Technologies (A) | United States | $39.625B | 25.05 |
| GE HealthCare Technologies (GEHC) | United States | $36.943B | 17.67 |
| Koninklijke Philips (PHG) | Netherlands | $28.127B | 18.37 |
| Terumo (TRUMY) | Japan | $20.195B | 22.73 |
| Insulet (PODD) | United States | $20.046B | 62.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.153B | 10.70 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.928B | 0.00 |
| Baxter (BAX) | United States | $10.132B | 8.18 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.404B | 30.22 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.406B | 13.42 |
| Envista Holdings (NVST) | United States | $4.056B | 23.27 |
| BillionToOne (BLLN) | United States | $3.850B | 0.00 |
| ICU Medical (ICUI) | United States | $3.830B | 24.32 |
| Haemonetics (HAE) | United States | $3.282B | 14.61 |
| Prestige Consumer Healthcare (PBH) | United States | $3.222B | 14.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.147B | 47.00 |
| Perrigo (PRGO) | Ireland | $2.052B | 5.14 |
| QuidelOrtho (QDEL) | United States | $1.999B | 12.85 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| AtriCure (ATRC) | United States | $1.952B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.700B | 16.98 |
| Curaleaf Holdings (CURLF) | Canada | $1.649B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.608B | 70.46 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.431B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.425B | 20.63 |
| Kestra Medical Technologies (KMTS) | United States | $1.377B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.230B | 365.00 |
| Capricor Therapeutics (CAPR) | United States | $1.111B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.010B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.893B | 10.09 |
| Omeros (OMER) | United States | $0.856B | 0.00 |
| Valneva SE (VALN) | France | $0.854B | 0.00 |
| CeriBell (CBLL) | United States | $0.822B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 16.08 |
| Verano Holdings (VRNO) | United States | $0.494B | 0.00 |
| Cerus (CERS) | United States | $0.486B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Cresco Labs (CRLBF) | United States | $0.422B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.420B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Quanterix (QTRX) | United States | $0.329B | 0.00 |
| Evolus (EOLS) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.285B | 22.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| Sanuwave Health (SNWV) | United States | $0.236B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.234B | 0.00 |
| High Tide (HITI) | Canada | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.201B | 17.73 |
| OraSure Technologies (OSUR) | United States | $0.199B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Accendra Health (ACH) | United States | $0.166B | 1.66 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.156B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.84 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.105B | 4.58 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 26.15 |
| Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 35.08 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.19 |
| Bonk (BNKK) | United States | $0.025B | 0.00 |
| Jin Medical (ZJYL) | China | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |